Patents Assigned to GENEOSCOPY, INC.
  • Detection method for cancer using RNA biomarkers
    Patent number: 11479824
    Abstract: Provided herein are materials and methods for detecting colorectal neoplasms and colon cancer based on the expression levels of stool-derived eukaryotic RNA biomarkers in eukaryotic nucleic acid present in a stool sample from a subject, for example, a patient. The methods can be used for the detection of high-risk adenomas and colorectal neoplasm molecular subtypes.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: October 25, 2022
    Assignee: GENEOSCOPY, INC.
    Inventors: Andrew Barnell, Erica Barnell, Yiming Kang, Elizabeth Wurtzler, Katie Campbell
  • Detection method using eukaryotic cells
    Patent number: 11479820
    Abstract: Provided herein are materials and methods for isolation of eukaryotic nucleic acid from a human or non-human animal stool sample. Also provided are methods of analysis of eukaryotic biomarkers present in a human or non-human animal stool sample.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: October 25, 2022
    Assignee: GENEOSCOPY, INC.
    Inventors: Erica Barnell, Andrew Barnell, Yiming Kang, Elizabeth Wurtzler